USCAST 2024 Virtual Public Meeting
Ceftriaxone and Azithromycin STIC against N. gonorrhoeae
Sujata N. Bhavnani, Pharm. D.
Vice Chair, USCAST
Oral cephalosporin STIC against S. aureus and E. coli
David Andes, MD
Executive Committee Member, USCAST
Trimethoprim-Sulfamethoxazole STIC against Enterobacterales Uncomplicated Urinary Tract Infections
Jason M. Pogue, Pharm. D.
Chairman, USCAST
USCAST 2023 Virtual Public Meeting
Piperacillin/Tazobactam STIC: Enterobacterales and P. aeruginosa
Thomas Lodise, Pharm. D.
Executive Committee, USCAST
Re-Evaluation of Aminoglycoside
In Vitro Susceptibility Test Criteria
Sujata Bhavnani, Pharm. D.
Vice Chair, USCAST
2019 USCAST Annual Public Meeting
Susceptibility Breakpoints: The Peril of Using the ECOFF
Sujata M. Bhavnani, Pharm. D., M.S.
DOWNLOAD SLIDES
Machine Learning and AI: The End of Susceptibility Breakpoints?
Michael N. Dudley, Pharm. D.
DOWNLOAD SLIDES
Old Antibiotic Breakpoint Reevaluations: An Urgent Unmet Medical Need
Paul G. Ambrose, Pharm. D.
DOWNLOAD SLIDES
2018 USCAST Annual Public Meeting
Beta-lactamase Inhibitor PK/PD and Breakpoint Considerations
Paul G. Ambrose, Pharm. D.
DOWNLOAD SLIDES
Antimicrobial Stewardship Challenges Posed by Suboptimal Breakpoints
Jason M. Pogue, Pharm. D.
DOWNLOAD SLIDES
Aminoglycosides: Re-Evaluation of PK-PD Target Attainment and Breakpoints
Sujata M. Bhavnani, Pharm. D., M.S.
DOWNLOAD SLIDES
USCAST 2017 Annual Public Meeting
Polymyxin (colistin and polymyxin B) Breakpoints
Jason M. Pogue, Pharm. D.
Michael N. Dudley, Pharm. D.
Keith A. Rodvold, Pharm. D.
DOWNLOAD SLIDES
Tetracycline Breakpoint Harmonization Project: Preparation for New Drugs in an Old Class
Ronald N. Jones, MD
David R. Andes, MD
DOWNLOAD SLIDES